ScottEugenePautlerMDFACS

PubMed

• 153 citations
  Bilateral Diffuse Uveal Melanocytic Proliferation in Patients With Occult Carcinoma
  J. Donald M. Gass, Richard G. Gieser, Charles P. Wilkinson, Donald E. Beahm, Scott E. Pautler
  Archives of Ophthalmology. 1990-04-01
• 23 citations
  Long-term visual and anatomic outcomes of patients with peripapillary pachychoroid syndrome.
  David Xu, Elisha C Garg, Kook Lee, Yoichi Sakurada, Atchara Amphornphruet
  The British Journal of Ophthalmology. 2020-12-20
• 29 citations
  Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
  John H. Kempen, Mark L. Van Natta, Michael M. Altaweel, James P. Dunn, Douglas A. Jabs
  American Journal of Ophthalmology. 2015-12-01

Journal Articles

• Beta Blocker Use and Age-Related Macular Degeneration  
  Davis A, Cohen SM, Pautler SE, Billiris-Findlay K, Eishenbaum DA, Acta Ophthalmologyogica, 1/1/2013
• The Multicenter Uveitis Steroid Treatment Trial: Rationale, Design, and Baseline Characteristics  
  The Multicenter Uveitis Steroid Treatment Trial Research Group, Pautler S, Am J Ophthalmology, 4/1/2010
• Recalcitrant Candida endophthalmitis associated with mannose-binding lectin deficiency  
  Oliva AM, Pavan PR, Margo CE, Pautler SE, Arch Ophthalmology, 6/1/2009
• Night Vision Symptoms and Progression of Age-related Macular Degeneration in the Complications of Age-related Macular Degeneration Prevention Trial  
  Ying GS, Maguire MG, Liu C, Antoszyk AN, Ophthalmology, 7/30/2008
• Predicting Response Of Vitreous Hemorrhage And Outcome Of Photocoagulation After Intravitreous Injection Of Highly Purified Ovine Hyaluronidase in Patients with Diabetes  
  Bhavsar A, Grillone L, McNamara T, Gow J, Hochberg A, Pearson R, Invest Ophthalmology Vis Sci, 4/25/2008
• Characteristics of Choroidal Neovascularization in the Complications of Age-Related Macular Degeneration Prevention Trial  
  Maguire MG, Alexander J, Fine SL, Ophthalmology, 1/1/2008
• Risk factors for Choroidal Neovascularization and Geographic Atrophy in the Complications of Age-Related Macular Degeneration Prevention Trial  
  CAPT Coordinating Center, Pautler SE, Ophthalmology, 1/1/2008
• Hydroxychloroquine dosages should be calculated using lean body mass (letter)  
  Pautler SE, Arch Ophthalmol, 1/1/2007
• OCT Findings in Group 2A Idiopathic Juxtafoveal Retinal Telangiectasis  
  Cohen SM., Pautler SE, Cohen, ML, Fayssal El-Jabali, Retina, 1/1/2007
• Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage  
  Kuppermann BD, Thomas EL, de S, Grillone LR, Am J Ophthalmology, 1/1/2005
• Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitras...  
  Kuppermann BD, Thomas EL, de S, Grillone LR, Am J Ophthalmology, 1/1/2005
• Adult AIDS Clinical Trials Group and the Studies of Ocular Complications of AIDS Research Group  Results of a cytomegalovirus (CMV)-specific CD8+/interferon- gamma+ cy...  
  Jacobson MA, Maecker HT, Orr PL, D’Amico R, Van Natta M, Li XD, Pollard RB, Bredt BM, J Infect Dis, 4/15/2004
• Studies of Ocular Complications of AIDS Research Group, Avidity of antibodies to cytomegalovirus in HIV-seropositive patients with and without CMV retinitis  
  Marshall BC, Jacobson MA, Adler SP, Viral Immunol, 1/1/2004
• Argon laser vs subthreshold infrared (810-nm) diode laser macular grid photocoagulation in nonexudative age-related macular degeneration  
  Scorolli L, Corazza D, Morara M, Vismara S, Lugaresi ML, Meduri RA, Can J Ophthalmology, 1/1/2003
• Hyaluronidase (Vitrase)--ISTA: hyaluronidase--ISTA pharmaceuticals  
  Pautler SE, Drugs R D, 1/1/2003
• Vitrase ISTA Pharmaceuticals  
  Czajka M, Fekrat S, IDrugs, 1/1/2002
• Retinal detachment in the endophthalmitis vitrectomy study  
  Doft BM, Kelsey SF, Wisniewski SR, Arch Ophthalmology, 1/1/2000
• Characteristics after cataract extraction or secondary lens implantation among patients screened for the Endophthalmitis Vitrectomy Study  
  Wisniewski SR, Capone A, Kelsey SF, Groer-Fitzgerald S, Lambert HM, Doft BH, Ophthalmology, 1/1/2000
• Additional procedures after the initial vitrectomy or tap-biopsy in the Endophthalmitis Vitrectomy Study  
  Doft BH, Kelsey SF, Wisniewski SR, Ophthalmology, 4/1/1998
• Cystoid Macular Edema Associated with Latanoprost in Aphakic and Pseudophakic Eyes  
  Ayyala RS, Cruz DA, Margo CE, Harman LE, Pautler SE, Misch DA, Mines JA, and Richards, DW, Am J Opthalmol , 1/1/1998
• A Long Term Follow Up of Choroidal Osteoma  
  Aylward GW, Chang TS, Pautler SE, Gass JDM, Arch Ophthalmology, 1/1/1998
• Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study  
  Barza M, Pavan PR, Doft BH et al, Arch Ophthalmology, 9/1/1997
• An investigation of the hospital charges related to the treatment of endophthalmitis in the Endophthalmitis Vitrectomy Study  
  Wisniewski SR, Hammer ME, Grizzard WS et al, Ophthalmology, 5/1/1997
• The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study A comparison of eyelid and intraocular isolates using pulsed-field gel electroph...  
  Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA, Arch Ophthalmology, 3/1/1997
• The Endophthalmitis Vitrectomy Study Relationship between clinical presentation and microbiologic spectrum  
  Johnson MW, Doft BH, Kelsey SF et al, Ophthalmology, 2/1/1997
• Join now to see all